One 30-year-old patient with a family history of BC (HT163B1) has a germline frameshift variant of unknown significance (p.Y1672fs) in BRCA2 that has significant loss of heterozygosity in the tumor (FDR = 0.0001). This evidence concerns the gene BRCA2 and breast cancer.